The PATHWAYS puberty blocker trial is not ‘following the Cass Review’

Image by freepik Patient safety and evidence-based care must be the priority for the NHS regarding medical interventions for children. The PATHWAYS puberty blocker trial is not a prioritisation of…

Continue ReadingThe PATHWAYS puberty blocker trial is not ‘following the Cass Review’

PATHWAYS puberty blocker trial is a return to pre-Cass activism

NHS England has finally released the PATHWAYS puberty blocker trial protocol. The reason it’s almost a year late could reasonably be supposed to be because of the impossibility of the…

Continue ReadingPATHWAYS puberty blocker trial is a return to pre-Cass activism

‘Affirmative gender care’ at The Bridge clinic

Activist GPs are offering ‘affirmative gender care’ and bridging prescriptions for hormones. With no age limits on who can attend these special clinics, we’re concerned that once 18 young people…

Continue Reading‘Affirmative gender care’ at The Bridge clinic

Court refuses to treat provision of cross-sex hormones to child over 16 as an exceptional case

[Note: the judge referred to Child Q as ‘he’ throughout. We refer to Child Q as a girl for clarity of understanding]. The second recent case concerning a teenage girl’s…

Continue ReadingCourt refuses to treat provision of cross-sex hormones to child over 16 as an exceptional case